In the present study we primarily test for association between eleven SNPs spanning GABRA2, and alcohol dependence and alcohol consumption measures, in a sample of 4597 individuals representative of the general Australian population. With data available on tobacco, cannabis and illicit drug use measures, we then expanded our analyses to test whether the pathway from GABRA2 genetic variation to alcohol-related outcomes may also modulate risk for these frequently co-occurring substance-use disorders.
